Human Vaccines & Immunotherapeutics

译名:人用疫苗与免疫治疗学

SCIEJCR Q2中科院3区

3-5

2026

影响因子区间

平台估算

投稿周期

39%

2025

中国作者发文占比

5085 AUD;3505 EUR;2920 GBP;3650 USD

费用说明

收费

期刊简介:(formerly Human Vaccines; issn 1554-8619)Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics.Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.

【译文】疫苗研究和开发正在将其范围扩展到细菌或病毒疾病的预防之外。有实验性疫苗用于免疫治疗目的,以及用于传染病以外的应用,如癌症、自身免疫、过敏、阿尔茨海默病和成瘾。这些疫苗和免疫治疗中的许多将在未来二十年成为可用,从而对人类健康产生益处。该领域的持续进步将受益于一个能够(A)通过保持研究人员更新来促进兴趣,以及(B)能够交换关于疫苗和免疫治疗许多相关主题最新进展的论坛。Human Vaccines & Immunotherapeutics提供了这样一个论坛。它每月出版一次,以一个便于广泛的国际学术界、工业界和公众领域的受众访问的格式出版。

出版社
Taylor & Francis
语言
English
学科
医学
ISSN
2164-5515
eISSN
2164-554X
出版频率
月刊
创刊年份
2005
投稿网址
https://www.editorialmanager.com/HV
最近更新
2026-04-02 18:16:40
Human Vaccines & Immunotherapeutics

指标当前值近三年趋势
JCR分区Q2
暂无
中科院分区3区
暂无
影响因子区间3-5
暂无